HUNTINGTON’S DISEASE: ORPHAN DISEASE
Dr. Kathleen Shannon is the spearhead of the Illinois Chapter of the Huntington's Disease Society of America. This article specifically is an interview with Dr. Shannon concerning a new treatment of one of the most traumatic symptoms of Huntington’s Disease (HD): chorea. Specifically, the drug tentrabenazine, which depletes the amount of dopamine in the nervous system, has been found to significantly help control the involuntary movements that severely impair the patient’s quality of life. Dr. Shannon is an extremely talented neurologist who is located in Chicago, IL. She has published numerous articles concerning movement disorders, with special attention to Parkinson’s and Huntington’s Disease. Because Huntington’s Disease is a hereditary disease it also effects the family’s quality of life. This is why research of this disorder is so important; its symptoms reach far past the patient themselves. There is a whole website dedicated to helping not only HD patients and their families. There are numerous stories of the struggles associated with having the disease and being a caregiver of someone who suffers from this disease. Despite Huntington’s Disease being an “orphan disease” ,which Dr. Shannon defines as a disease effecting less than 200,000 people, it deserves attention. Dr. Shannon also has a clip on youtube explaining how she became interested in neurology and why the study and treatment of movement disorders are important to her, which I hope also speaks to you as a neurology student. As a caregiver of someone who has this disease it is important to me to spread the word about what it is and who can help, and I appreciate anyone taking the time to learn about it.